RNA Avidity Biosciences, Inc. - Common Stock
$12.84
가격 · 5월 20, 2026
기준 재무 정보 2월 23, 2026
52주 범위
$12–$73
1% of range
애널리스트 평점
BUY
5 analysts
목표 주가
$25
+95% upside
P/E (TTM)
-14.5
ROE
-47.5%
순이익률
-3650.4%
RNA 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$12.84
시가총액
$10.91B
P/E (TTM)
-14.5
EPS (TTM)
$-4.97
매출 (TTM)
$19M
배당 수익률
—
ROE
-47.5%
부채/자본
—
52주 범위
$12 – $73
RNA 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$19M
2018-12-31
→
2025-12-31
EPS
$-4.97
2020-12-31
→
2025-12-31
잉여현금흐름
$-664M
2020-12-31
→
2025-12-31
마진
-3650.4%
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
RNA
동종업계 중앙값
P/E (TTM)
-14.5
2.4
P/S (TTM)
581.5
15.2
P/B
6.5
1.4
Price / FCF (주가 / FCF)
-16.4
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
RNA
동종업계 중앙값
Operating Margin (영업이익률)
-3977.3%
—
Net Profit Margin (순이익률)
-3650.4%
-946.2%
ROA
-38.9%
-52.8%
ROE
-47.5%
-60.2%
ROIC
-44.2%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
RNA
동종업계 중앙값
Current Ratio (유동비율)
9.2
7.4
Quick Ratio (당좌 비율)
2.0
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
RNA
동종업계 중앙값
Revenue YoY (매출 YoY)
72.1%
—
Revenue CAGR 3Y (매출 CAGR 3년)
26.7%
—
Revenue CAGR 5Y (매출 CAGR 5년)
22.5%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
RNA
동종업계 중앙값
RNA 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
5 명의 애널리스트
- 적극 매수 1 20.0%
- 매수 3 60.0%
- 보유 1 20.0%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
2 명의 애널리스트 · 2026-05-20
저가
$25.00
고가
$25.00
중앙값 목표
$25.00
+94.8%
평균 목표
$25.00
+94.8%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.09%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 3월 31일 | $-0.97 | $-1.06 | 0.09% |
동료 비교 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| FATE | $113M | -0.9 | -51.2% | -2051.1% | -58.2% | — |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| IKT | $270M | -4.2 | 111.0% | -1299.0% | -38.2% | — |
| KROS | $398M | 8.9 | — | 35.7% | 17.2% | — |
| BDTX | $139M | 6.2 | — | 31.9% | 18.3% | — |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | — |
| UNCY | $128M | -3.5 | -29.0% | — | -113.9% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 15
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $11M | $10M | $9M | · | $9M | $7M | $2M | |
| R&D Expense | $559M | $304M | $191M | $150M | · | $101M | $38M | $15M | |
| SG&A Expense | $206M | $86M | $54M | $38M | · | $26M | $13M | $5M | |
| Operating Expenses | $765M | $390M | $245M | $188M | · | $127M | $51M | $20M | |
| Operating Income | $-746M | $-379M | $-236M | $-179M | · | $-118M | $-44M | $-17M | |
| Interest Expense | · | · | · | $0 | · | $0 | $209.0K | $7M | |
| Other Non-op | $-2M | $-248.0K | $-594.0K | $-57.0K | · | $-62.0K | $-75.0K | $0 | |
| Pretax Income | $-685M | $-322M | $-212M | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | |
| Net Income | $-685M | $-322M | $-212M | $-174M | · | $-118M | $-44M | $-25M | |
| EPS (Basic) | $-4.97 | $-2.89 | $-2.91 | $-3.34 | · | $-2.85 | $-2.05 | · | |
| EPS (Diluted) | $-4.97 | $-2.89 | $-2.91 | $-3.34 | · | $-2.85 | $-2.05 | · | |
| Shares (Basic) | 137,710,000 | 111,582,000 | 73,012,000 | 52,162,000 | · | 41,428,000 | 21,663,000 | · | |
| Shares (Diluted) | 137,710,000 | 111,582,000 | 73,012,000 | 52,162,000 | · | 41,428,000 | 21,663,000 | · | |
| EBITDA | $-746M | $-379M | $-236M | $-179M | · | $-118M | $-44M | · |
대차대조표 24
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $383M | $220M | $185M | $340M | · | $320M | $321M | $95M | |
| Short-term Investments | · | · | · | · | · | $85M | $7M | · | |
| Receivables | · | $0 | $1M | $2M | · | · | · | · | |
| Prepaid Expense | $102M | $41M | $16M | $12M | · | $6M | · | · | |
| Other Current Assets | $53M | $19M | · | $2M | · | · | · | · | |
| Current Assets | $1.80B | $1.54B | $611M | $623M | · | $411M | $332M | $96M | |
| PP&E (Net) | $23M | $13M | $8M | $6M | · | $5M | $1M | $631.0K | |
| PP&E (Gross) | $35M | $21M | $14M | $9M | · | $7M | $3M | $2M | |
| Accum. Depreciation | $12M | $8M | $5M | $3M | · | $2M | $2M | $2M | |
| Other Non-current Assets | $82M | $521.0K | $301.0K | $598.0K | · | $599.0K | $47.0K | $600.0K | |
| Total Assets | $1.96B | $1.56B | $629M | $639M | · | $428M | $334M | $97M | |
| Accounts Payable | $12M | $8M | $9M | $5M | · | $3M | $8M | $2M | |
| Current Liabilities | $195M | $98M | $81M | $52M | · | $30M | $15M | $10M | |
| Capital Leases | $45M | $3M | $6M | $8M | · | $10M | $938.0K | $393.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $45.0K | |
| Total Liabilities | $269M | $139M | $128M | $61M | · | $46M | $28M | $28M | |
| Long-term Debt | · | · | · | · | · | · | · | $5M | |
| Common Stock | $15.0K | $12.0K | $8.0K | $7.0K | · | $5.0K | $4.0K | $0 | |
| Paid-in Capital | · | · | · | $939M | · | $566M | $373M | $-43M | |
| Retained Earnings | $-1.58B | $-893M | $-571M | $-359M | · | $-185M | $-67M | $-22M | |
| AOCI | $3M | $3M | $125.0K | $-3M | · | $-187.0K | $-5.0K | · | |
| Stockholders' Equity | $1.69B | $1.42B | $501M | $578M | $374M | $381M | $306M | $-65M | |
| Liabilities + Equity | $1.96B | $1.56B | $629M | $639M | · | $428M | $334M | $97M | |
| Shares Outstanding | 151,205,000 | 119,893,000 | 79,275,000 | 69,768,000 | 52,081,000 | 47,754,000 | 37,569,000 | 2,989,000 |
현금 흐름 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $98M | $51M | $38M | $27M | · | $17M | $4M | $406.0K | |
| Operating Cash Flow | $-650M | $-301M | $-119M | $-136M | · | $-95M | $-37M | $2M | |
| CapEx | $13M | $7M | $4M | $3M | · | $4M | $1M | $235.0K | |
| Investing Cash Flow | $-38M | $-854M | $-130M | $-190M | · | $-83M | $-8M | $-235.0K | |
| Net Debt Issued | · | · | · | $0 | · | $0 | $-5M | · | |
| Stock Issued | $837M | $762M | $61M | $345M | $82M | $175M | $274M | · | |
| Net Stock Activity | $837M | $762M | $61M | $345M | $82M | $20M | · | · | |
| Financing Cash Flow | $851M | $1.19B | $94M | $346M | · | $176M | $272M | $89M | |
| Net Change in Cash | $163M | $37M | $-155M | $20M | · | $-1M | $227M | $91M | |
| Free Cash Flow | $-664M | $-308M | $-123M | $-139M | · | $-99M | $-38M | · |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3977.3% | -3477.4% | -2464.4% | -1939.6% | · | -1265.8% | -652.4% | · | |
| Net Margin | -3650.4% | -2957.7% | -2219.9% | -1886.3% | · | -1265.4% | -653.5% | · | |
| Pretax Margin | -3650.4% | · | · | · | · | · | · | · | |
| EBITDA Margin | -3977.3% | -3477.4% | -2464.4% | -1939.6% | · | -1265.8% | -652.4% | · | |
| ROA | -38.9% | -29.4% | -33.5% | -32.6% | · | -31.0% | -20.6% | · | |
| ROE | -47.5% | -22.0% | -41.7% | -36.4% | · | -30.4% | -14.2% | · | |
| ROIC | -44.2% | · | · | · | · | · | · | · |
유동성 및 지급능력 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.2 | 15.7 | 7.6 | 12.0 | · | 13.9 | 22.7 | · | |
| Quick Ratio | 2.0 | 2.2 | 2.3 | 6.6 | · | 13.7 | 22.5 | · | |
| Interest Coverage | · | · | · | · | · | · | -211.9 | · |
효율성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | |
| Receivables Turnover | · | 19.7 | 5.5 | · | · | · | · | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 72.1% | 14.0% | 3.6% | -1.1% | · | 37.4% | · | · | |
| Revenue CAGR 3Y | 26.7% | 5.3% | 12.1% | · | · | · | · | · | |
| Revenue CAGR 5Y | 22.5% | · | · | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19M | $11M | $10M | $9M | $9M | $9M | $7M | · | |
| Net Income TTM | $-685M | $-322M | $-212M | $-174M | $-136M | $-118M | $-44M | · | |
| Market Cap | $10.91B | $3.49B | $717M | $1.55B | · | $1.14B | $959M | · | |
| P/E | -14.5 | -10.1 | -3.1 | -6.6 | -4.8 | -8.3 | -12.4 | · | |
| P/S | 581.5 | 319.9 | 75.0 | 167.8 | · | 121.7 | 141.3 | · | |
| P/B | 6.5 | 2.4 | 1.4 | 2.7 | · | 3.0 | 3.1 | · | |
| P / Tangible Book | 6.5 | 2.4 | 1.4 | 2.7 | · | 3.0 | 3.1 | · | |
| P / Cash Flow | -16.8 | -11.6 | -6.0 | -11.4 | · | -12.0 | -25.8 | · | |
| P / FCF | -16.4 | -11.3 | -5.8 | -11.1 | · | -11.5 | -25.1 | · | |
| Earnings Yield | -6.9% | -9.9% | -32.1% | -15.0% | -20.7% | -12.0% | -8.0% | · |
손익계산서 12
| 지표 | 추세 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $860.0K | $12M | $4M | $2M | $3M | $2M | $2M | $4M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | |
| R&D Expense | $167M | $155M | $138M | $99M | $96M | $77M | $64M | $67M | $53M | $48M | $43M | $48M | $46M | $37M | $40M | $28M | |
| SG&A Expense | $89M | $46M | $37M | $34M | $28M | $23M | $21M | $14M | $16M | $14M | $12M | $12M | $10M | $10M | $9M | $9M | |
| Operating Expenses | $255M | $201M | $175M | $133M | $124M | $100M | $85M | $81M | $69M | $61M | $55M | $60M | $56M | $47M | $48M | $36M | |
| Operating Income | $-254M | $-189M | $-171M | $-132M | $-121M | $-98M | $-83M | $-77M | $-67M | $-59M | $-53M | $-58M | $-53M | $-45M | $-46M | $-34M | |
| Other Non-op | $-477.0K | $-380.0K | $-651.0K | $-435.0K | $201.0K | $-232.0K | $-116.0K | $-101.0K | $-105.0K | $-13.0K | $-162.0K | $-314.0K | $-18.0K | $-12.0K | $-2.0K | $-25.0K | |
| Net Income | $-237M | $-174M | $-157M | $-116M | $-102M | $-80M | $-71M | $-69M | $-60M | $-52M | $-47M | $-52M | $-50M | $-44M | $-46M | $-34M | |
| EPS (Basic) | $-1.59 | $-1.27 | $-1.21 | $-0.90 | $-0.80 | $-0.65 | $-0.65 | $-0.79 | $-0.80 | $-0.71 | $-0.66 | $-0.74 | $-0.89 | $-0.82 | $-0.92 | $-0.71 | |
| EPS (Diluted) | $-1.59 | $-1.27 | $-1.21 | $-0.90 | $-0.80 | $-0.65 | $-0.65 | $-0.79 | $-0.80 | $-0.71 | $-0.66 | $-0.74 | $-0.89 | $-0.82 | $-0.92 | $-0.71 | |
| Shares (Basic) | -259,039,000 | 137,895,000 | 129,622,000 | 129,232,000 | -205,933,000 | 123,375,000 | 106,928,000 | 87,212,000 | -142,908,000 | 74,097,000 | 71,390,000 | 70,433,000 | -99,080,000 | 53,069,000 | 49,927,000 | 48,246,000 | |
| Shares (Diluted) | -259,039,000 | 137,895,000 | 129,622,000 | 129,232,000 | -205,933,000 | 123,375,000 | 106,928,000 | 87,212,000 | -142,908,000 | 74,097,000 | 71,390,000 | 70,433,000 | -99,080,000 | 53,069,000 | 49,927,000 | 48,246,000 | |
| EBITDA | · | $-189M | $-171M | $-132M | · | $-98M | $-83M | $-77M | · | $-59M | $-53M | $-58M | · | $-45M | · | $-34M |
대차대조표 21
| 지표 | 추세 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $383M | $350M | $244M | $254M | $220M | $370M | $576M | $471M | · | $86M | $154M | $119M | · | $144M | $125M | $139M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | $262M | $273M | $258M | |
| Receivables | · | · | · | · | · | $0 | $0 | $2M | · | · | $1M | · | · | · | · | · | |
| Prepaid Expense | $102M | $90M | $67M | $55M | $41M | $33M | $30M | $19M | · | · | $11M | · | · | · | · | · | |
| Other Current Assets | $53M | $60M | $43M | · | $19M | · | · | · | · | · | $6M | · | · | · | · | · | |
| Current Assets | $1.80B | $1.97B | $1.25B | $1.43B | $1.54B | $1.62B | $1.33B | $934M | · | $555M | $595M | $597M | · | $414M | $404M | $405M | |
| PP&E (Net) | $23M | $22M | $21M | $16M | $13M | $9M | $8M | $9M | · | $8M | $8M | $8M | · | $6M | $6M | $5M | |
| PP&E (Gross) | $35M | $32M | $30M | $24M | $21M | $17M | $15M | $15M | · | $13M | $12M | $11M | · | $9M | $9M | $7M | |
| Accum. Depreciation | $12M | $10M | $10M | $9M | $8M | $7M | $7M | $6M | · | $5M | $4M | $4M | · | $3M | $2M | $2M | |
| Other Non-current Assets | $82M | $91M | $91M | $739.0K | $521.0K | $318.0K | $364.0K | $425.0K | · | $344.0K | $424.0K | $474.0K | · | $523.0K | $415.0K | $548.0K | |
| Total Assets | $1.96B | $2.13B | $1.37B | $1.46B | $1.56B | $1.64B | $1.35B | $951M | · | $573M | $611M | $614M | · | $431M | $421M | $421M | |
| Accounts Payable | $12M | $10M | $4M | $7M | $8M | $8M | $9M | $2M | · | $6M | $6M | $4M | · | $26M | $21M | $19M | |
| Current Liabilities | $195M | $170M | $135M | $85M | $98M | $91M | $84M | $75M | · | $49M | $45M | $48M | · | $43M | $34M | $31M | |
| Capital Leases | $45M | $46M | $1M | $2M | $3M | $4M | $5M | $5M | · | $7M | $6M | $7M | · | $8M | $9M | $9M | |
| Total Liabilities | $269M | $248M | $176M | $130M | $139M | $137M | $126M | $121M | · | $56M | $52M | $55M | · | $54M | $46M | $45M | |
| Common Stock | $15.0K | $15.0K | $12.0K | $12.0K | $12.0K | $12.0K | $11.0K | $10.0K | · | $7.0K | $7.0K | $7.0K | · | $5.0K | $5.0K | $5.0K | |
| Retained Earnings | $-1.58B | $-1.34B | $-1.17B | $-1.01B | $-893M | $-791M | $-710M | $-640M | · | $-510M | $-458M | $-411M | · | $-308M | $-264M | $-219M | |
| AOCI | $3M | $2M | $2M | $3M | $3M | $7M | $-453.0K | $-464.0K | · | $-2M | $-3M | $-2M | · | $-3M | $-3M | $-2M | |
| Stockholders' Equity | $1.69B | $1.89B | $1.19B | $1.33B | $1.42B | $1.50B | $1.22B | $831M | $501M | $517M | $559M | $559M | $578M | $377M | $374M | $376M | |
| Liabilities + Equity | $1.96B | $2.13B | $1.37B | $1.46B | $1.56B | $1.64B | $1.35B | $951M | · | $573M | $611M | $614M | · | $431M | $421M | $421M | |
| Shares Outstanding | 151,205,000 | 146,771,000 | 120,778,000 | 120,512,000 | 119,893,000 | 118,900,000 | 109,266,000 | 95,594,000 | 79,275,000 | 74,101,000 | 74,070,000 | 70,813,000 | 69,768,000 | 54,446,000 | 52,081,000 | 49,281,000 |
현금 흐름 9
| 지표 | 추세 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $43M | $19M | $18M | $18M | $14M | $14M | $13M | $10M | $10M | $10M | $9M | $9M | $7M | $7M | $7M | $6M | |
| Operating Cash Flow | $-170M | $-156M | $-200M | $-125M | $-100M | $-66M | $-65M | $-70M | $17M | $-37M | $-50M | $-49M | $-39M | $-32M | $-36M | $-30M | |
| CapEx | $6M | $712.0K | $3M | $4M | $4M | $2M | $531.0K | $915.0K | $863.0K | $923.0K | $622.0K | $2M | $850.0K | $-107.0K | $1M | $758.0K | |
| Investing Cash Flow | $207M | $-588M | $185M | $157M | $-64M | $-482M | $-275M | $-33M | $51M | $-31M | $46M | $-196M | $-8M | $11M | $-18M | $-175M | |
| Stock Issued | $-538.0K | $837M | $0 | $0 | $-500.0K | $324M | $433M | $6M | $0 | $0 | $38M | $22M | $243M | $39M | $38M | $24M | |
| Net Stock Activity | · | · | · | $0 | · | · | · | $6M | · | · | · | $22M | · | · | · | $24M | |
| Financing Cash Flow | $-5M | $850M | $4M | $2M | $14M | $342M | $447M | $389M | $32M | $40.0K | $39M | $23M | $244M | $40M | $39M | $24M | |
| Net Change in Cash | $32M | $106M | $-10M | $34M | $-150M | $-206M | $107M | $286M | $99M | $-68M | $35M | $-222M | $197M | $19M | $-14M | $-181M | |
| Free Cash Flow | · | · | · | $-129M | · | · | · | $-71M | · | · | · | $-51M | · | · | · | $-30M |
수익성 5
| 지표 | 추세 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1513.5% | -4448.7% | -8360.9% | · | -4200.9% | -4040.4% | -2178.6% | · | -2080.4% | -2272.6% | -2579.3% | · | -1810.2% | · | -1919.8% | |
| Net Margin | · | -1398.3% | -4089.3% | -7360.0% | · | -3441.7% | -3461.8% | -1943.4% | · | -1858.0% | -2030.4% | -2346.3% | · | -1756.6% | · | -1907.2% | |
| EBITDA Margin | · | -1513.5% | -4448.7% | -8360.9% | · | -4200.9% | -4040.4% | -2178.6% | · | -2080.4% | -2272.6% | -2579.3% | · | -1810.2% | · | -1919.8% | |
| ROA | · | -9.2% | -11.6% | -9.6% | · | -7.3% | -7.2% | -8.8% | · | -10.4% | -9.1% | -10.1% | · | -10.2% | · | -9.3% | |
| ROE | · | -10.3% | -13.0% | -10.7% | · | -8.0% | -8.0% | -9.9% | · | -11.7% | -10.1% | -11.2% | · | -11.3% | · | -10.3% |
유동성 및 지급능력 2
| 지표 | 추세 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 11.6 | 9.3 | 16.9 | · | 17.8 | 15.8 | 12.5 | · | 11.4 | 13.1 | 12.4 | · | 9.7 | · | 13.1 | |
| Quick Ratio | · | 2.1 | 1.8 | 3.0 | · | 4.1 | 6.8 | 6.3 | · | 1.8 | 3.4 | 2.5 | · | 9.5 | · | 12.8 |
효율성 2
| 지표 | 추세 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 3.5 | 4.5 | · | · | 3.9 | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $20M | $10M | $9M | · | $11M | $11M | $11M | · | $10M | $9M | $9M | · | $9M | · | $9M | |
| Net Income TTM | · | $-528M | $-424M | $-336M | · | $-272M | $-239M | $-221M | · | $-195M | $-189M | $-176M | · | $-153M | · | $-114M | |
| Market Cap | · | $6.39B | $3.43B | $3.56B | · | $5.46B | $4.46B | $2.44B | · | $473M | $821M | $1.09B | · | $889M | · | $910M | |
| P/E | · | -10.8 | -8.3 | -9.9 | · | -16.4 | -14.5 | -8.8 | · | -2.2 | -3.5 | -4.8 | · | -5.2 | · | · | |
| P/S | · | 316.1 | 350.0 | 374.6 | · | 508.4 | 416.3 | 223.6 | · | 48.0 | 89.2 | 125.1 | · | 103.2 | · | 98.2 | |
| P/B | · | 3.4 | 2.9 | 2.7 | · | 3.6 | 3.7 | 2.9 | · | 0.9 | 1.5 | 1.9 | · | 2.4 | · | 2.4 | |
| P / Tangible Book | · | 3.4 | 2.9 | 2.7 | · | 3.6 | 3.7 | 2.9 | · | 0.9 | 1.5 | 1.9 | · | 2.4 | · | 2.4 | |
| P / Cash Flow | · | · | · | -28.5 | · | · | · | -34.7 | · | · | · | -22.2 | · | · | · | -30.8 | |
| P / FCF | · | · | · | -27.7 | · | · | · | -34.2 | · | · | · | -21.4 | · | · | · | -30.0 | |
| Earnings Yield | · | -9.2% | -12.0% | -10.1% | · | -6.1% | -6.9% | -11.4% | · | -45.9% | -28.3% | -20.8% | · | -19.2% | · | · |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $19M | $11M | $10M | $9M | $9M |
| 영업이익률 % | -3977.3% | -3477.4% | -2464.4% | -1939.6% | -1265.8% |
| 순이익 | $-685M | $-322M | $-212M | $-174M | $-118M |
| 희석 EPS | $-4.97 | $-2.89 | $-2.91 | $-3.34 | $-2.85 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 9.2 | 15.7 | 7.6 | 12.0 | 13.9 |
| 당좌 비율 | 2.0 | 2.2 | 2.3 | 6.6 | 13.7 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-664M | $-308M | $-123M | $-139M | $-99M |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.